NEET-PG 2012 - Obstetrics and Gynecology Practice Questions

Q: What is the primary use of prophylactic methergin?

To stop excess bleeding from uterus. ***To stop excess bleeding from uterus*** - **Methergin (Methylergonovine)** is an **ergot alkaloid** that causes strong contractions of the **uterus**. - Its primary prophylactic use is to **prevent or treat postpartum hemorrhage** by contracting the uterus and compressing blood vessels. *Induction of labour* - **Methergin** is generally **contraindicated for labor induction** as its potent, sustained contractions can cause **hypertonic uterine dysfunction** and fetal distress. - **Oxytocin** is the preferred agent for **labor induction** due to its more physiological contraction pattern. *Induction of abortion* - While methergin can cause uterine contractions, it is **not the primary agent for abortion induction**. - **Prostaglandins (e.g., misoprostol)** and other pharmacological agents are typically used in combination for **medical abortion**. *None of the options* - This option is incorrect because **stopping excess uterine bleeding** is indeed a primary use of prophylactic methergin, particularly in the postpartum period. - The other options describe situations where methergin is either not indicated or is a secondary/contraindicated choice.

Q: After delivery upto which week is known as puerperium?

6 weeks. ***6 weeks*** - The **puerperium** is the period of approximately **6 weeks** after childbirth during which the mother's body undergoes physiological adaptations to return to its non-pregnant state. - This timeframe allows for the involution of the uterus and the restoration of reproductive organs and systemic physiology. *2 weeks* - This period is too short to encompass the full physiological recovery process after childbirth. - While immediate postpartum changes occur, many maternal systems, such as the reproductive organs, have not fully reverted to their pre-pregnancy state within 2 weeks. *4 weeks* - This duration is still considered an incomplete period for the extensive physiological changes that define the puerperium. - Uterine involution often continues beyond 4 weeks, and other hormonal and systemic adjustments are still ongoing. *8 weeks* - While recovery continues, the primary definition of the puerperium typically concludes at **6 weeks postpartum**. - By 8 weeks, most significant physiological changes have already occurred, and the body is largely back to its pre-pregnant state.

Q: Which of the following pelvic measurements is most commonly used in clinical practice?

Diagonal conjugate. ***Diagonal conjugate*** - This measurement is the most commonly used in clinical practice due to its **accessibility** and ability to estimate the **obstetrical conjugate**, which indicates the true AP diameter of the pelvic inlet. - It is measured vaginally from the **lower border of the symphysis pubis** to the **sacral promontory**. *Anteroposterior diameter of inlet* - This measurement, also known as the **obstetrical conjugate**, truly represents the narrowest AP diameter for fetal passage through the inlet. - However, it cannot be measured directly clinically and must be estimated from the diagonal conjugate or imaging. *Transverse diameter of outlet* - This measurement is important for assessing the **midpelvis** and **pelvic outlet**, but it is less commonly the primary measurement used for initial pelvic assessment compared to the diagonal conjugate. - A compromised transverse diameter can indicate a generally contracted pelvis or **android/anthropoid pelvic shapes**, which may lead to obstructed labor. *Oblique diameter of pelvis* - The oblique diameter provides information about the **symmetry of the pelvis**, but it is not routinely measured clinically unless there is suspicion of pelvic asymmetry or disease. - Significant asymmetry, often due to injury or disease (e.g., **scoliosis**, polio), can complicate labor by misdirecting the fetal head.

Q: What is thelarche?

Hormone-related breast development in girls. ***Hormone-related breast enlargement in girls*** - **Thelarche** specifically refers to the first sign of puberty in girls, which is the **onset of breast development**. - This development is primarily driven by the action of **estrogen** on breast tissue. *Breast development in boys during puberty* - This condition is known as **gynecomastia**, which is distinguishable from thelarche observed in girls. - While also hormone-related, **gynecomastia** often involves an imbalance between estrogen and androgens. *Breast enlargement during pregnancy* - Breast enlargement during pregnancy is a normal physiological change in preparation for lactation, driven by a surge in various hormones like **estrogen, progesterone, and prolactin**. - It is distinct from the initial, puberty-related breast development in girls. *Breast enlargement due to hormonal therapy in postmenopausal women* - This is an induced effect of **exogenous hormones** (e.g., hormone replacement therapy) and not a natural developmental stage like thelarche. - It is a side effect of medication, not the start of puberty.

Q: Which IUD is preferred for menorrhagia?

Mirena. ***Mirena*** - The **Mirena** IUD contains **levonorgestrel**, a progestin, which significantly reduces menstrual blood loss by causing endometrial atrophy. - It is FDA-approved for the treatment of **menorrhagia** and is highly effective in reducing heavy menstrual bleeding. *NOVA T* - **NOVA T** is a **copper IUD**, which can actually *increase* menstrual blood loss and dysmenorrhea, making it unsuitable for menorrhagia. - Copper IUDs work primarily by inducing a **local inflammatory reaction** in the uterus that is spermicidal and prevents fertilization. *Cu IUD* - Like NOVA T, **copper IUDs (Cu IUDs)** are known to exacerbate **heavy menstrual bleeding** and cramping. - They are used for contraception but are generally contraindicated in women with pre-existing menorrhagia. *Gynefix* - **Gynefix** is a frameless copper IUD designed to reduce the side effects of traditional T-shaped copper IUDs. - While it may cause less cramping than other copper IUDs, it still contains copper and can **increase menstrual flow**, making it a poor choice for menorrhagia.

Q: Which fetal presentation is the rarest?

Shoulder. ***Shoulder*** - **Shoulder presentation** (also known as a **transverse lie**) occurs in approximately **0.3% of pregnancies** at term, making it the rarest presentation among the major fetal lie categories. - In this presentation, the fetal long axis is perpendicular to the maternal long axis, and the **shoulder** is typically the presenting part. - Vaginal delivery is not possible, and **cesarean section is mandatory**. *Cephalic* - **Cephalic presentation** is the most common presentation, occurring in about **95% of pregnancies**. - In this presentation, the fetal head is directed downwards towards the maternal pelvis. - This includes vertex, face, brow, and other head-first presentations. *Breech* - **Breech presentation** occurs when the fetal buttocks or feet are the presenting part, seen in about **3-4% of term pregnancies**. - While less common than cephalic, it is significantly more frequent than shoulder presentation. - Includes frank, complete, and footling breech variants. *Face* - **Face presentation** is a rare variant of cephalic presentation where the **fetal face** (chin/mentum) is the presenting part, occurring in about **0.2-0.3% of deliveries**. - The fetal head is hyperextended, with the occiput against the fetal back. - While rare, it is still slightly more common than shoulder presentation in some studies.

Q: Which of the following statements about cholestasis of pregnancy is false?

Most common cause of jaundice in pregnancy. ***Most common cause of jaundice in pregnancy*** - This statement is **FALSE** - while **intrahepatic cholestasis of pregnancy (ICP)** is the most common **pregnancy-specific** cause of jaundice, it is NOT the most common cause of jaundice overall in pregnancy. - **Viral hepatitis** (especially hepatitis A, B, and E) remains the **most common cause of jaundice in pregnancy** worldwide, accounting for approximately 40-50% of cases. - ICP accounts for about 20-25% of jaundice cases in pregnancy, making it the leading obstetric-specific cause but not the overall leading cause. *Bilirubin level >2mg%* - In ICP, **bilirubin levels** are typically **normal or only mildly elevated** (usually 10 μmol/L), not bilirubin. *Oestrogen is involved* - **TRUE** - Elevated **estrogen and progesterone levels** during pregnancy play a key role in ICP pathophysiology. - These hormones affect **hepatic bile salt transporters** (particularly BSEP and MDR3), leading to impaired bile secretion in genetically susceptible individuals. *Manifestations usually appear in last trimester* - **TRUE** - ICP typically presents in the **third trimester** (usually after 28 weeks), with **pruritus** as the predominant symptom. - Symptoms resolve within days to weeks after delivery, correlating with declining hormone levels.

Q: What is the treatment for uterine prolapse in nulliparous women?

Manchester operation. ***Manchester operation*** - This procedure is sometimes considered for **nulliparous women** with uterine prolapse, particularly if combined with cervical elongation. - It involves **amputation of the cervix** and support of the cardinal ligaments, which can address the prolapse while preserving uterine function. *Sling used involving rectus sheath* - A sling using the rectus sheath is typically employed for **stress urinary incontinence**, not primarily for uterine prolapse. - While it supports the urethra and bladder neck, it does not directly address the descent of the uterus. *Anterior colporrhaphy* - This procedure repairs a **cystocele** (prolapse of the bladder into the vagina) by tightening the anterior vaginal wall. - It does not directly manage **uterine prolapse** itself, though a cystocele can coexist with uterine descent. *Posterior colporrhaphy* - This surgical repair targets a **rectocele** (prolapse of the rectum into the vagina) by tightening the posterior vaginal wall. - Similar to anterior colporrhaphy, it addresses a specific vaginal wall defect rather than the **uterine position**.

Q: What is the presenting part in a transverse lie?

Shoulder. ***Shoulder*** - In a **transverse lie**, the fetal **shoulder** is the part that presents over the pelvic inlet. - This occurs when the fetal long axis is 90 degrees to the maternal spine. *Face* - A **face presentation** is a type of **cephalic presentation** where the head is hyperextended, and the face is the presenting part. - This is not characteristic of a transverse lie. *Vertex* - A **vertex presentation** is the most common and ideal **cephalic presentation**, where the head is flexed and the top of the head (vertex) is the presenting part. - This indicates a longitudinal lie, not a transverse lie. *Brow* - A **brow presentation** is also a type of **cephalic presentation** where the fetal head is partially extended, and the brow is the presenting part. - Like vertex and face presentations, this occurs with a longitudinal fetal lie.

Q: What is the definitive treatment for preeclampsia?

Delivery of the baby. ***Delivery of the baby*** - **Preeclampsia** is a multisystem disorder of pregnancy; its pathogenesis is directly linked to the **placenta**. - **Removal of the placenta** through delivery is the only definitive cure for preeclampsia, leading to the resolution of symptoms. *Use of antihypertensive medications* - Antihypertensive medications are used to **manage blood pressure** in preeclampsia, preventing complications like stroke. - They **do not address the underlying cause** of the disease and are not a curative treatment. *Dietary modifications* - While a healthy diet is important during pregnancy, **dietary modifications** alone cannot resolve the pathological processes of preeclampsia. - There is **no specific diet** proven to cure or prevent preeclampsia. *Increased rest and monitoring* - **Increased rest and close monitoring** are supportive measures that can help manage symptoms and detect complications. - These interventions **do not reverse the disease process** and are not a definitive treatment.

Question 1

What is the primary use of prophylactic methergin?

Accepted Answer

To stop excess bleeding from uterus

Answer

None of the options

Answer

Induction of labour

Answer

Induction of abortion

Question 2

After delivery upto which week is known as puerperium?

Accepted Answer

6 weeks

Answer

2 weeks

Answer

4 weeks

Answer

8 weeks

Question 3

Which of the following pelvic measurements is most commonly used in clinical practice?

Accepted Answer

Diagonal conjugate

Answer

Transverse diameter of outlet

Answer

Oblique diameter of pelvis

Answer

Anteroposterior diameter of inlet

Question 4

What is thelarche?

Accepted Answer

Hormone-related breast development in girls

Answer

Breast development in boys during puberty

Answer

Breast enlargement during pregnancy

Answer

Breast enlargement due to hormonal therapy in postmenopausal women

Question 5

Which IUD is preferred for menorrhagia?

Accepted Answer

Mirena

Answer

NOVA T

Answer

Cu IUD

Answer

Gynefix

Question 6

Which fetal presentation is the rarest?

Accepted Answer

Shoulder

Answer

Cephalic

Answer

Breech

Answer

Face

Question 7

Which of the following statements about cholestasis of pregnancy is false?

Accepted Answer

Most common cause of jaundice in pregnancy

Answer

Bilirubin level >2mg%

Answer

Oestrogen is involved

Answer

Manifestations usually appear in last trimester

Question 8

What is the treatment for uterine prolapse in nulliparous women?

Accepted Answer

Manchester operation

Answer

Anterior colporrhaphy

Answer

Posterior colporrhaphy

Answer

Sling used involving rectus sheath

Question 9

What is the presenting part in a transverse lie?

Accepted Answer

Shoulder

Answer

Face

Answer

Vertex

Answer

Brow

Question 10

What is the definitive treatment for preeclampsia?

Accepted Answer

Delivery of the baby

Answer

Use of antihypertensive medications

Answer

Dietary modifications

Answer

Increased rest and monitoring

NEET-PG 2012 — Obstetrics and Gynecology